CBLL (CeriBell) 3-1 Month Momentum %: 1.27% (As of Jul. 12, 2026)


CBLL CeriBell Inc CBLL
12 GF Score
Price $19.58
! 4 Warning Signs
View Full Analysis

What is CeriBell 3-1 Month Momentum %?

CeriBell CBLL -0.41% 12 3-1 Month Momentum % is 1.27% as of Jul. 12, 2026. GuruFocus rates CBLL with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 849 Medical Devices & Instruments companies, CeriBell ranks better than 69.26% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-12), CeriBell's 3-1 Month Momentum % is 1.27%.

The industry rank for CeriBell's 3-1 Month Momentum % or its related term are showing as below:

CBLL's 3-1 Month Momentum % is ranked better than
69.26% of 849 companies
in the Medical Devices & Instruments industry
Industry Median: -6.91 vs CBLL: 1.27

CeriBell  (NAS:CBLL) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

CeriBell 3-1 Month Momentum % Related Terms

CBLL vs BBNX, SIBN, TCMD: 3-1 Month Momentum % Comparison

For the Medical Devices subindustry, CeriBell's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CeriBell 3-1 Month Momentum % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CeriBell's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where CeriBell's 3-1 Month Momentum % falls into.


CBLL
12GF Score
CeriBell Inc CBLL
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CeriBell  (NAS:CBLL) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of 1.27% mean?
CeriBell (CBLL) has a 3-1 Month Momentum % of 1.27% as of Jul. 12, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on CeriBell and its competitors. According to the industry distribution chart, CeriBell ranks #261 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 30.7%.
Is CeriBell's 3-1 Month Momentum % too high?
CeriBell's current 3-1 Month Momentum % is 1.27%. Based on the distribution chart, CeriBell ranks #261 out of 849 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, CeriBell has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does CeriBell's 3-1 Month Momentum % compare to BBNX and SIBN?
According to the Medical Devices & Instruments industry distribution chart, CeriBell ranks #261 out of 849 companies for 3-1 Month Momentum %. This puts CeriBell in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on CeriBell and its competitors. CeriBell's current 3-1 Month Momentum % is 1.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CeriBell stock overvalued right now?
CeriBell (CBLL) has a current 3-1 Month Momentum % of 1.27%. The current 3-1 Month Momentum % is 1.27%. CeriBell's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For CeriBell (CBLL), the current 3-1 Month Momentum % is 1.27% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CeriBell Business Description

Address 360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
12GF Score

Get the complete analysis for CBLL

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.58
Price